e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Genetics, genomics and exposures in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure
Kim De Jong (Groningen, Netherlands), K. De Jong, J.M. Vonk, D.A. Van der Plaat, C.C. Van Diemen, H. Kromhout, R. Vermeulen, C.M. Van Duijn, D.S. Postma, H.M. Boezen
Source:
International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Session:
Genetics, genomics and exposures in asthma and COPD
Session type:
Oral Presentation
Number:
1456
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kim De Jong (Groningen, Netherlands), K. De Jong, J.M. Vonk, D.A. Van der Plaat, C.C. Van Diemen, H. Kromhout, R. Vermeulen, C.M. Van Duijn, D.S. Postma, H.M. Boezen. Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure. Eur Respir J 2015; 46: Suppl. 59, 1456
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Occupational exposure to pesticides is associated with excess lung function decline in a general population
Source: Annual Congress 2013 –From air pollution during pregnancy to respiratory diseases at work
Year: 2013
Identification of novel genes related to airway obstruction in never-smokers
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
Gene-by-occupational exposure interaction and gene expression analysis on the level of FEV
1
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
Genetic differences in COPD secondary to wood smoke and tobacco smoking
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
TNF promoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Occupational asthma induced by exposure to high and low molecular weight agents. Similarities and differences
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013
Prevalence and risk factors of COPD among never-smokers in two areas of Sweden - Occupational exposure to gas, dust or fumes is an important risk factor
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Association between lung function decline and occupational exposures in patients with COPD
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
The interaction between family history of COPD, personal smoking and post-bronchodilator airflow obstruction: A cohort study
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Differences in association between endotoxin and asthma and wheeze with environmental exposures
Source: International Congress 2015 – Indoor air and ambient pollution
Year: 2015
Relationship between the influence of exposure to tobacco smoke and max-IMT, ABI, ratio of EPA / AA in COPD patients
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
Differences in COPD: Smokers versus non smokers
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Contribution of host factors and workplace exposure to the outcome of occupational asthma
Source: Eur Respir Rev 2012; 21: 88-96
Year: 2012
Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Influence of smoking on respiratory function and status of proteinas-inhibitory system in patients COPD
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014
Physiological and inflammatory phenotypic comparisons between non-smoking and smoking COPD
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016
Influence of gene-by-early environmental tobacco smoke exposure interactions on time-to-asthma onset
Source: International Congress 2016 – Predictors of asthma among children and adults
Year: 2016
Plasma surfactant protein D (SP-D) and smoking status in patients with COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept